key: cord-0993512-h3yk47ya authors: Cakir, Murat; Guven, Burcu; Issi, Fatma; Ozkaya, Esra title: New‐onset celiac disease in children during COVID‐19 pandemic date: 2021-11-11 journal: Acta Paediatr DOI: 10.1111/apa.16173 sha: 20efa216ac13f1e0ca4d0685697a32101f353a40 doc_id: 993512 cord_uid: h3yk47ya AIM: We aimed to analyse the influence of the COVID‐19 pandemic on the frequency and clinical presentation of celiac disease. METHODS: The study included the patients with celiac disease since January 2008. They were divided into 2 groups (diagnosed in pre‐pandemic [January 2008 and February 2020] [n = 148] and in pandemic period [March 2020 and June 2021] [n = 47]). Clinical and histological findings were compared between groups. Additionally, data about severe acute respiratory syndrome coronavirus 2 infection were obtained in subgroup patients (n = 22) with celiac disease diagnosed during pandemic period. RESULTS: The number of patients per year (12.1–37.6) and the percentage of patients who were diagnosed with celiac disease/total endoscopy were increased during the pandemic period (2.2% vs. 10%, p < 0.00001). The association of celiac disease with type 1 diabetes mellitus was significantly high in pandemic period (4% vs. 17%, p = 0.002). Frequency of moderate‐severe mucosal lesions was low in pandemic period (42.4% vs. 81.7%, p = 0.0001). Clinical and laboratory markers for the past severe acute respiratory syndrome coronavirus 2 infection were found in 36.3% of patients diagnosed during the pandemic period. CONCLUSION: It seems that the frequency of celiac disease and its association with type 1 diabetes mellitus is increased during the COVID‐19 pandemic in children. mediating pathological remodelling of small gut mucosa manifest as villous atrophy and crypt hyperplasia that the characteristic features of CD. Simultaneously, CD 4 + T cells cooperate with B cells to differentiate into plasmatic cells and secrete specific antibodies against transglutaminase 2. 2, 3 Although gluten is the major trigger for CD, some studies suggest that microorganisms may also play a role in the pathogenesis of CD and can influence the disease onset, clinical presentation and progression. Molecular mimicry may play a pathogenic role between antigenic epitopes of viral proteins and gliadins via shared antigenic determinants. It is believed that reoviridae, adenoviruses, the respiratory syncytial virus, herpes simplex type 1, hepatitis C and B viruses, enteroviruses, influenza virus, cytomegalovirus and Epstein-Barr virus might play role in CD development. 4 In December 2019, a novel outbreak of a new strain of coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) infection emerged in Wuhan, China. The disease was declared as a pandemic in early March 2020. 5 Initially, it seems that children with COVID-19 have mild symptoms and require hospitalisation rarely. 6 In April 2020, it was shown that COVID-19 could lead to autoimmune and autoinflammatory diseases, such as multisystem inflammatory syndrome in children (MISC). 7 Thereafter, COVID-19 has been implicated in the initiation of chronic inflammatory or autoimmune diseases in adult patients. 8 Additionally, an increased incidence and severe clinical presentation of type 1 diabetes mellitus (DM) have been reported in children during the COVID-19 pandemic. 9 Although SARS-CoV-2 may primarily enter the cells of the lungs, the small bowel may also be an important entry site, as the enterocytes are rich in angiotensin-converting enzyme (ACE)-2 and transmembrane serine protease 2 (TMPRSS2) receptors. 10 Post-mortem animal studies have demonstrated SARS-CoV-2 infection causes diffuse mucosal damage and impairs the intestinal barrier resulting in increased intestinal permeability that may allow the passage of gliadin peptides to intestinal lamina easily. 10, 11 Therefore, an outbreak of CD may be seen in the forthcoming feature after SARS-CoV-2 infection. We aimed to analyse the influence of the COVID-19 pandemic, on the frequency and clinical presentation of CD in our centre. The study included the patients with CD since January 2008 in our centre (n = 195). They were divided into 2 groups: group 1; patient with CD diagnosed between January 2008 and February 2020 (prepandemic period) (n = 148) and group 2; patients with CD diagnosed between March 2020 and June 2021 (pandemic period) (n = 47). Although histopathological examination is not mandatory according to ESPGHAN 2012 and 2020 guidelines, we made the final diagnosis of CD according to histopathological examination in all patients in pre-pandemic period, but we could not able to perform histopathological examination in 14 patients in the pandemic period due to strict lockdown guidelines. 12, 13 Their diagnosis was made by positive results of all three parameters: tissue transglutaminase antibody IgA Our hospital is a tertiary care hospital and mainly serve patients in 6 cities (Trabzon, Giresun, Rize, Artvin, Gümüşhane and Bayburt). Our unit is the only paediatric gastroenterology centre that all the patients who are suspected or with positive serology are referred to our centre, but the nearest paediatric gastroenterology unit (Erzurum) was closed in the half of 2019, and the patients were also referred to our centre since then. The clinical spectrum of the patients was divided into two categories according to the main symptoms: (i) typical CD, clinical malabsorption, chronic diarrhoea or failure to thrive; and (ii) atypical CD, abdominal pain, iron deficiency anaemia, chronic hypertransaminasaemia, constipation or screening of risk groups. 14 Nutritional status of patients was classified as obese if body mass index was >95 percentile. Histopathological findings compatible with >Marsh 3a lesions were accepted as 'moderate-severe', and others were accepted as 'mild' mucosal lesions (Marsh 2-3a). 15 We also divided the patients into two groups according to their referral cities (inside patients; Trabzon, Giresun, Rize, Artvin, Gümüşhane and Bayburt, and outside patients; patients from other cities) in order to analyse effect of patients' referral on to the frequency of new cases during the pandemic. Additionally, some data about SARS-CoV-2 infection (such as antibody positivity, diagnostic PCR positivity or contact history) were obtained in a subgroup patient (n = 22) with CD diagnosed during pandemic period from another ongoing study in our centre. The study was conducted according to the Helsinki Declarations, with ethical approvals obtained from the Ethics Committee of the KTU Institutional Ethics Committee (study number: 2021/259). Statistical analysis was performed using the SPSS version 16 .0 software (SPSS Inc.). Continuous variables were expressed in • Outbreak of celiac disease may be seen in the forthcoming feature after SARS-CoV-2 infection, and we aimed to analyse the influence of the COVID-19 pandemic on celiac disease. • It seems that both frequency of celiac disease and association of celiac disease with type 1 diabetes mellitus was increased in the pandemic period. • With the prolonged duration of pandemic, it seems that the COVID-19 pandemic will show us unexpected novel features in near future. mean±standard deviation (SD), and categorical variables were expressed in number and percentage. Comparison of the quantitative data between the groups was performed using Student's t test in the normally distributed variables and Mann-Whitney test in the nonnormally distributed variables, whereas qualitative data were compared using chi-square test. Celiac disease was diagnosed in 47 patients (29 between March and December 2020, and 18 between January and June 2021) during pandemic period. There were 148 patients in prepandemic period (between January 2008 and February 2020). The demographic, clinical and histological findings of the patients in two periods are shown in Table 1 In this study, we report the demographic and clinical characteristics of the patients with CD diagnosed during the pandemic period, and we compared them with the patients diagnosed during pre-pandemic period. We found that (i) the frequency of the pa- [16] [17] [18] [19] [20] It was shown that gastrointestinal tractus serve as a nidus for in CD adult and paediatric patients was evaluated, and the studies showed no increased risk of for the contracting, hospitalisation, severity and poor outcome for COVID-19 in patients with CD, 16, 17, 27 but there has been no study that analyse the risk of developing CD after SARS-CoV-2 infection. In addition, we found an increased frequency of type In our study, we found that mucosal lesions of the patients with CD diagnosed during the pandemic period were milder compared with pre-pandemic period. It may be related with short time span from the initiation of pandemic to the diagnosis of patients. Additionally, mild mucosal lesions may be a feature of virus- period may be small for to make a generalisable conclusion, but it may be supported by multicentre studies. In conclusion, we share our experience about the clinical characteristics of children with CD diagnosed during the pandemic period and its association with SARS-CoV-2 infection. It seems that the frequency of CD and its association with type 1 DM is increased during the COVID-19 pandemic. Mucosal lesions are generally mild. With the prolonged duration of pandemic, it seems that the COVID-19 pandemic will show us unexpected novel features such as outbreak of functional gastrointestinal disease or inflammatory bowel disease in the near future. https://orcid.org/0000-0003-4071-6129 Celiac disease: a comprehensive current review Pathogenesis of celiac disease and other gluten related disorders in wheat and strategies for mitigating them Coeliac disease pathogenesis: the uncertainties of a well-known immune mediated disorder Contribution of infectious agents to the development of celiac disease Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital Covid-19 and autoimmunity New-onset type 1 diabetes in finnish children during the COVID-19 pandemic Intestinal barrier function in health and diseaseany role of SARS-CoV-2? Microorganisms Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease European society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease 2020 Atypical celiac disease: from recognizing to managing Coeliac disease: an update for pathologists Prevalence of COVID-19 in Italian children with celiac disease: a cross-sectional study The risk of contracting COVID-19 is not increased in patients with celiac disease COVID-19 and celiac disease: a pathogenetic hypothesis for a celiac outbreak A negative fallout of COVID-19 lockdown in Italy: life-threatening delay in the diagnosis of celiac disease Where have all the other coeliacs gone in 2020? Road for a 2021 catch-up with missed diagnoses Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis Evidence for gastrointestinal infection of SARS-CoV-2 Intestinal permeability and the prediction of relapse in Crohn's disease zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease ESPGHAN 'biopsysparing' guidelines for celiac disease in children with low antitransglutaminase during COVID-19 Risk of severe covid-19 in patients with celiac disease: a population-based cohort study Autoimmune diabetes mellitus and the leaky gut Type 1 diabetes triggered by covid-19 pandemic: a potential outbreak? New-onset celiac disease in children during COVID-19 pandemic